Gamida Cell to Present at Upcoming January Investor Conferences
January 05 2021 - 4:01PM
Business Wire
Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy
company committed to cures for blood cancers and serious blood
diseases, announced today that company management will participate
in two upcoming investor conferences in January:
- H.C. Wainwright Bioconnect 2021 Conference, January 11-14,
2021. Company presentation will be available for on-demand viewing
at 6:00 a.m. ET on Monday, January 11, 2021.
- 15th Annual Stern IR Corporate Access Event, January 11-14,
2021. Company presentation will be available for on-demand viewing
at 7:00 a.m. ET on Monday, January 11, 2021. Management will also
be available for one-on-one meetings from Monday, January
11-Thursday, January 14, 2021.
A webcast of each presentation will be available on the
“Investors & Media” section of Gamida Cell’s website at
www.gamida-cell.com. Replays of the webcast will be available on
the company’s website for at least 14 days following the event.
About Gamida Cell
Gamida Cell is an advanced cell therapy company committed to
cures for patients with blood cancers and serious blood diseases.
We harness our cell expansion platform to create therapies with the
potential to redefine standards of care in areas of serious medical
need. For additional information, please visit www.gamida-cell.com
or follow Gamida Cell on LinkedIn or Twitter at @GamidaCellTx.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210105005829/en/
For investors: Stephanie Ascher Stern Investor Relations, Inc.
stephanie.ascher@sternir.com 1-212-362-1200
For media: Matthew Corcoran Ten Bridge Communications
mcorcoran@tenbridgecommunications.com 1-617-866-7350
Gamida Cell (NASDAQ:GMDA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Gamida Cell (NASDAQ:GMDA)
Historical Stock Chart
From Sep 2023 to Sep 2024